Suprit D. Saoji

Employment

• Lonza Associate Director
  2026 - Present
• Hetero Labs Ltd Senior Manager
  2024 - 2026
• Dr. Reddy's Laboratories (India) Specialist
  2023 - 2024
• Slayback Pharma Manager
  2020 - 2023
• Granules India Ltd Assistant Manager
  2019 - 2020
• Alkem (India) Senior Scientist
  2016 - 2019

Education

• National Academy of Legal Studies and Research Post Graduate Diploma Patent Laws
  2021 - 2022
• Department of Pharmaceutical Sciences, RTM Nagpur University Doctor of Philosophy
  2013 - 2015
• Government College of Pharmacy Master of Pharmacy
  2009 - 2011
• Government College of Pharmacy Bachelor of Pharmacy
  2005 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (38)

• Translating nanopharmaceuticals to the clinic
  Multifunctional Nano pharmaceuticals for Biomedical Applications 2027 DOI: 10.1016/b978-0-443-44119-6.00023-9
  +Save
• Development and Optimization of Apremilast-Loaded Cubosomes for Enhanced Topical Delivery and Psoriasis Management
  Journal of Pharmaceutical Innovation 2026 DOI: 10.1007/s12247-026-10686-9
  +Save
• Bioengineered nanocomposite bacitracin zinc-loaded chitosan microspheres containing keratin/gelatine films for wound healing
  Journal of Drug Targeting 2026 DOI: 10.1080/1061186X.2025.2554758
  +Save
• Quality by Design (QbD)-Improved Polymeric Micelles of Posaconazole with Increased Solubility, Oral Bioavailability, and Antifungal Activity against Invasive Fungal Infections
  Journal of Pharmaceutical Innovation 2026 DOI: 10.1007/s12247-025-10335-7
  +Save
• Development and in silico, in vitro and in vivo biological evaluation of flutamide-loaded potato starch-chitosan-lactoferrin nanoparticles as promising candidates for targeted colorectal cancer therapy
  Journal of Dispersion Science and Technology 2026 DOI: 10.1080/01932691.2026.2661848
  +Save
• Advancements in Cubosomes: A Promising Platform for Targeted Anticancer Drug Delivery
  Indonesian Journal of Pharmacy 2026 DOI: 10.22146/ijp.28745
  +Save
• Mesoporous Silica Nanoparticles for Improved Solubility and Bioavailability of Pazopanib in the Treatment of Renal Cell Carcinoma
  Journal of Pharmaceutical Innovation 2026 DOI: 10.1007/s12247-026-10458-5
  +Save
• Phospholipid-Based Lurasidone Hydrochloride Complex: Formulation, Characterization, Biorelevant Dissolution with IVIVC Correlation, and Enhanced Bioavailability
  BioNanoScience 2026 DOI: 10.1007/s12668-026-02698-z
  +Save
• Nilotinib Tartrate Encapsulated Polycaprolactone Polymeric Nanoparticle Fabricated With Lactoferrin for the Treatment of Colorectal Cancer: In-Silico and In-Vitro Investigation
  BioNanoScience 2026 DOI: 10.1007/s12668-026-02727-x
  +Save
• Formulation and evaluation of etoposide-loaded dextran polymeric nanoparticles fabricated with hyaluronic acid for the treatment of colorectal cancer using network pharmacology, in-silico , in-vitro , and in-vivo approaches
  Journal of Drug Targeting 2026 DOI: 10.1080/1061186X.2026.2709768
  +Save